period
novemb
adult
year
age
patient
region
hospit
hong
kong
special
administr
region
acut
gastroenter
shown
infect
noroviru
genogroup
clinic
record
review
baselin
characterist
clinic
featur
output
chart
studi
case
includ
analysi
stool
sampl
collect
hour
symptom
onset
diarrhea
defin
loos
stool
per
day
durat
diarrhea
defin
number
day
inclus
first
final
date
symptom
stool
sampl
collect
patient
initi
observ
process
immedi
rna
extract
diagnosi
noroviru
infect
quantit
base
realtim
revers
assay
stool
sampl
describ
lower
detect
limit
assay
copi
cdnag
stool
phylogenet
studi
also
perform
describ
associ
clinic
paramet
fecal
viral
cdna
concentr
determin
univari
associ
fecal
viral
concentr
copi
cdnag
fecal
specimen
baselin
characterist
clinic
variabl
examin
use
mannwhitney
test
test
appropri
variabl
p
valu
univari
analys
enter
multivari
model
covari
stepwis
backward
logist
regress
perform
identifi
independ
variabl
associ
prolong
diarrhea
defin
day
diarrhea
cutoff
base
result
mani
observ
studi
also
median
durat
diarrhea
cohort
spearman
rank
correl
coeffici
use
assess
correl
viral
cdna
concentr
continu
variabl
p
valu
consid
statist
signific
probabl
statist
analysi
perform
spss
softwar
version
spss
inc
chicago
il
usa
stool
sampl
patient
analyz
mean
sd
age
patient
year
male
seventeen
patient
preexist
medic
condit
hospit
diarrhea
observ
wherea
vomit
fever
observ
respect
median
durat
diarrhea
day
rang
day
median
fecal
cdna
concentr
copiesg
stool
interquartil
rang
copiesg
stool
fecal
viral
cdna
concentr
examin
relat
baselin
characterist
clinic
symptom
tabl
higher
viral
concentr
associ
older
age
p
higher
fecal
viral
concentr
significantli
associ
prolong
diarrhea
day
copiesg
stool
p
mannwhitney
test
limit
diarrhea
figur
viral
concentr
posit
correl
total
durat
diarrhea
spearman
p
total
frequenc
vomit
spearman
p
cours
ill
appendix
figur
fever
develop
frequent
patient
prolong
diarrhea
vs
p
test
mean
total
frequenc
diarrhea
vomit
respect
inpati
prolong
diarrhea
respect
limit
diarrhea
observ
associ
mean
daili
output
fecal
viral
concentr
cohort
rule
possibl
confound
variat
sampl
collect
time
fecal
viral
cdna
concentr
also
examin
sampl
collect
day
figur
gener
sampl
collect
patient
prolong
diarrhea
higher
viral
concentr
collect
day
mean
day
sampl
collect
slightli
later
patient
prolong
diarrhea
limit
symptom
day
vs
day
p
test
prolong
diarrhea
day
associ
older
age
preexist
medic
condit
univari
analys
p
variabl
test
fecal
viral
concentr
stepwis
backward
logist
regress
analysi
show
fecal
viral
concentr
odd
ratio
confid
interv
ci
per
copi
p
age
ci
per
year
p
independ
factor
associ
prolong
diarrhea
caus
noroviru
genotyp
knowledg
first
clinic
studi
demonstr
fecal
viral
concentr
correl
durat
ill
noroviru
gastroenter
report
sever
protract
diarrhea
caus
noroviru
infect
develop
hospit
elderli
immunocompromis
patient
patient
often
shed
viru
prolong
period
probabl
indic
activ
viral
replic
slow
viral
clearanc
anim
model
noroviru
shown
infect
possibl
replic
enterocyt
result
diseas
result
studi
thu
provid
preliminari
evid
activ
viral
replic
determin
clinic
diseas
noroviru
gastroenter
viral
infect
find
also
suggest
stringent
infect
control
measur
need
implement
patient
sever
diarrhea
high
fecal
viral
concentr
studi
limit
small
sampl
size
fecal
viral
concentr
studi
time
point
patient
research
chang
fecal
viral
concentr
relationship
diseas
sever
warrant
previou
clinic
studi
describ
tempor
chang
noroviru
concentr
relat
symptom
analyz
viral
concentr
data
patient
acut
diarrhea
day
although
definit
prolong
diarrhea
day
median
cohort
seem
arbitrari
support
result
mani
observ
studi
show
patient
even
elderli
hospit
patient
acut
symptom
subsid
within
day
inclus
noroviru
infect
analysi
remov
possibl
confound
strain
variat
viral
concentr
whether
similar
correl
observ
noroviru
strain
remain
uncertain
given
genogroup
predomin
circul
strain
countri
major
outbreak
result
implic
regard
pathogenesi
infect
control
noroviru
infect
conclus
result
provid
preliminari
evid
high
fecal
viral
concentr
independ
associ
prolong
noroviru
gastroenter
studi
need
confirm
role
enhanc
viral
replic
pathogenesi
transmiss
diseas
addit
approach
quantifi
noroviru
realtim
pcr
use
futur
evalu
antivir
treatment
studi
factor
associ
delay
viral
clearanc
